{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:36:21Z","timestamp":1791257781349,"version":"4.1.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Indian Acad Neurol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/aian.aian_201_18","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T05:31:00Z","timestamp":1545802260000},"page":"21","source":"Crossref","is-referenced-by-count":110,"title":["Propranolol: A 50-year historical perspective"],"prefix":"10.4103","volume":"22","author":[{"given":"AV","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-2327.248502-1","first-page":"336","volume-title":"Sir James black and propranolol.The role of the basic sciences in the history of cardiovascular pharmacology","author":"Stapleton","year":"1997","journal-title":"Tex Heart Inst J"},{"key":"key-10.4103\/0972-2327.248502-2","first-page":"370","volume-title":"The prophylactic value of propranolol in angina pectoris","author":"Rabkin","year":"1966","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0972-2327.248502-3","first-page":"11","volume-title":"Ahlquist and the development of beta-adrenoceptor antagonists","author":"Black","year":"1976","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/0972-2327.248502-4","first-page":"435","volume-title":"The pharmacological toolmaker's rational approach to drug design: An appreciation of Sir James Black","author":"Black","year":"1988","journal-title":"Trends Pharmacol Sci"},{"key":"key-10.4103\/0972-2327.248502-5","doi-asserted-by":"crossref","unstructured":"Quirke V. Black, James Whyte, Encyclopedia of Life Sciences. Vol. 20. London: Nature Publications Group; 2002. p. 300-1.","DOI":"10.1038\/npg.els.0002739"},{"key":"key-10.4103\/0972-2327.248502-6","first-page":"526","volume-title":"Clinical experiences with propranolol","author":"Besterman","year":"1965","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/0972-2327.248502-7","first-page":"7","volume-title":"Treatment of hypertension with propranolol","author":"Prichard","year":"1969","journal-title":"Br Med J"},{"key":"key-10.4103\/0972-2327.248502-8","first-page":"I53","volume-title":"Propranolol therapy in patients with acute myocardial infarction: The beta-blocker heart attack trial","author":"Goldstein","year":"1983","journal-title":"Circulation"},{"key":"key-10.4103\/0972-2327.248502-9","first-page":"40","volume-title":"Beta-blockers: Current state of knowledge and perspectives","author":"Ogrodowczyk","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"key-10.4103\/0972-2327.248502-10","first-page":"1316","volume-title":"Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state","author":"Turner","year":"1965","journal-title":"Lancet"},{"key":"key-10.4103\/0972-2327.248502-11","unstructured":"Inderal (Propranolol Hydrochloride). Cranford, NJ: Akrimax Pharmaceuticals, LLC; c2010. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/016418s080,016762s017, 017683s008lbl.pdf. [Last accessed on 2017 Oct 20]."},{"key":"key-10.4103\/0972-2327.248502-12","first-page":"73","volume-title":"Clinical pharmacokinetics of propranolol","author":"Routledge","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0972-2327.248502-13","first-page":"51","volume-title":"Pharmacokinetics of long acting propranolol.Implications for therapeutic use","author":"Nace","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0972-2327.248502-14","first-page":"724","volume-title":"Double-blind trial of Propranolol (INDERAL) in angina of effort","author":"Srivastava","year":"1964","journal-title":"Br Med J"},{"key":"key-10.4103\/0972-2327.248502-15","first-page":"346","volume-title":"Beta-blocker heart attack trial: Impact of propranolol therapy on ventricular arrhythmias","author":"Morganroth","year":"1985","journal-title":"Prev Med"},{"key":"key-10.4103\/0972-2327.248502-16","first-page":"676","volume-title":"The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction","author":"Lee","year":"2008","journal-title":"Angiology"},{"key":"key-10.4103\/0972-2327.248502-17","first-page":"115","volume-title":"Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias","author":"Barton","year":"2015","journal-title":"J Pediatr"},{"key":"key-10.4103\/0972-2327.248502-18","first-page":"1080","volume-title":"Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: Analysis of a large, national database","author":"Moffett","year":"2015","journal-title":"Cardiol Young"},{"key":"key-10.4103\/0972-2327.248502-19","first-page":"984","volume-title":"The study of antiarrhythmic medications in infancy (SAMIS): A multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants","author":"Sanatani","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key-10.4103\/0972-2327.248502-20","first-page":"1605","volume-title":"Propranolol versus digoxin in the neonate for supraventricular tachycardia (from the pediatric health information system)","author":"Bolin","year":"2017","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0972-2327.248502-21","first-page":"82","volume-title":"Beta-blockers in pediatric hypertrophic cardiomyopathies","author":"\u00d6stman-Smith","year":"2014","journal-title":"Rev Recent Clin Trials"},{"key":"key-10.4103\/0972-2327.248502-22","first-page":"940","volume-title":"Effect of \u03b2-blockers on platelet aggregation: A systematic review and meta-analysis","author":"Bonten","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0972-2327.248502-23","unstructured":"Starcevic V. Anxiety Disorders in Adults: A Clinical Guide. 2nd ed. New York: Oxford University Press; 2010."},{"key":"key-10.4103\/0972-2327.248502-24","first-page":"124","volume-title":"Addition of propranolol in resistant arterial hypertension treatment (APROPRIATE study): Study protocol for a randomized double-blind placebo-controlled trial","author":"Constantine","year":"2017","journal-title":"Trials"},{"key":"key-10.4103\/0972-2327.248502-25","first-page":"176","volume-title":"Migraine: Current concepts and emerging therapies","author":"Arulmozhi","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"key-10.4103\/0972-2327.248502-26","first-page":"26","volume-title":"Migraine: Prophylactic treatment","author":"Shukla","year":"2010","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0972-2327.248502-27","first-page":"1337","volume-title":"Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.248502-28","first-page":"651","volume-title":"Prophylactic treatment of migraine with propranolol.A clinical trial","author":"Borgesen","year":"1974","journal-title":"Acta Neurol Scand"},{"key":"key-10.4103\/0972-2327.248502-29","first-page":"268","volume-title":"Long-term study of propranolol in the treatment of migraine","author":"Diamond","year":"1982","journal-title":"Headache"},{"key":"key-10.4103\/0972-2327.248502-30","first-page":"92","volume-title":"Observations on the efficacy of propranolol for the prophylaxis of migraine","author":"Rosen","year":"1983","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.248502-31","first-page":"699","volume-title":"Propranolol in the treatment of migraine","author":"Wideroe","year":"1974","journal-title":"Br Med J"},{"key":"key-10.4103\/0972-2327.248502-32","first-page":"333","volume-title":"Propranolol in the management of recurrent migraine: A meta-analytic review","author":"Holroyd","year":"1991","journal-title":"Headache"},{"key":"key-10.4103\/0972-2327.248502-33","first-page":"CD003225","volume-title":"Propranolol for migraine prophylaxis","author":"Linde","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0972-2327.248502-34","first-page":"26","volume-title":"Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: Pairwise and network-meta analysis","author":"He","year":"2017","journal-title":"J Headache Pain"},{"key":"key-10.4103\/0972-2327.248502-35","first-page":"CD002761","volume-title":"Drugs for preventing migraine headaches in children","author":"Victor","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0972-2327.248502-36","first-page":"269","volume-title":"A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients","author":"Bidabadi","year":"2010","journal-title":"Paediatr Drugs"},{"key":"key-10.4103\/0972-2327.248502-37","first-page":"821","volume-title":"Essential tremor: Choosing the right management plan for your patient","author":"Abboud","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"key-10.4103\/0972-2327.248502-38","first-page":"43","volume-title":"Pharmacotherapy of essential tremor","author":"Hedera","year":"2013","journal-title":"J Cent Nerv Syst Dis"},{"key":"key-10.4103\/0972-2327.248502-39","first-page":"1752","volume-title":"Evidence-based guideline update: Treatment of essential tremor: Report of the quality standards subcommittee of the American Academy of Neurology","author":"Zesiewicz","year":"2011","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.248502-40","first-page":"S25","volume-title":"Guidelines for management of essential tremor","author":"Pal","year":"2011","journal-title":"Ann Indian Acad Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/0972-2327.248502-41","first-page":"88","volume-title":"Effect of beta blockade and beta stimulation on stage fright","author":"Brantigan","year":"1982","journal-title":"Am J Med"},{"key":"key-10.4103\/0972-2327.248502-42","first-page":"11","volume-title":"Propranolol reduces the anxiety associated with day case surgery","author":"Mealy","year":"1996","journal-title":"Eur J Surg"},{"key":"key-10.4103\/0972-2327.248502-43","first-page":"457","volume-title":"Oral propranolol \u2013 Efficacy and comparison of two doses for peri-operative anxiolysis","author":"Khadke","year":"2012","journal-title":"J Indian Med Assoc"},{"key":"key-10.4103\/0972-2327.248502-44","first-page":"448","volume-title":"Beta-blockers tackle memories of horror","author":"Giles","year":"2005","journal-title":"Nature"},{"key":"key-10.4103\/0972-2327.248502-45","first-page":"222","volume-title":"Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: A meta-analysis","author":"Lonergan","year":"2013","journal-title":"J Psychiatry Neurosci"},{"key":"key-10.4103\/0972-2327.248502-46","first-page":"947","volume-title":"Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma","author":"Vaiva","year":"2003","journal-title":"Biol Psychiatry"},{"key":"key-10.4103\/0972-2327.248502-47","first-page":"98","volume-title":"Propranolol's impact on cognitive performance in post-traumatic stress disorder","author":"Mahabir","year":"2016","journal-title":"J Affect Disord"},{"key":"key-10.4103\/0972-2327.248502-48","first-page":"1166","volume-title":"Treatment of portal hypertension","author":"Bari","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0972-2327.248502-49","first-page":"681","volume-title":"Clinical pharmacology of portal hypertension","author":"Mi\u00f1ano","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"key-10.4103\/0972-2327.248502-50","first-page":"5035","volume-title":"Portal hypertension and gastrointestinal bleeding: Diagnosis, prevention and management","author":"Biecker","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0972-2327.248502-51","first-page":"1013","volume-title":"A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis","author":"Patch","year":"2002","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0972-2327.248502-52","first-page":"1238","volume-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0972-2327.248502-53","first-page":"10464","volume-title":"Cost-effectiveness analysis of beta-blockers vs.endoscopic surveillance in patients with cirrhosis and small varices","author":"Di","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0972-2327.248502-54","first-page":"1189","volume-title":"Beta-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis","author":"Senzolo","year":"2009","journal-title":"Liver Int"},{"key":"key-10.4103\/0972-2327.248502-55","first-page":"969","volume-title":"Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: A single-centre prospective experience","author":"Heeb\u00f8ll","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"key-10.4103\/0972-2327.248502-56","first-page":"376","volume-title":"Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension","author":"Kim","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"key-10.4103\/0972-2327.248502-57","first-page":"169","volume-title":"The beneficial effect of beta-blockers in patients with cirrhosis, portal hypertension and ascites","author":"Aday","year":"2016","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/0972-2327.248502-58","first-page":"273","volume-title":"Propranolol and thyroid hormone metabolism","author":"Wiersinga","year":"1991","journal-title":"Thyroid"},{"key":"key-10.4103\/0972-2327.248502-59","first-page":"766","volume-title":"Propranolol and thyroidectomy in the treatment of thyrotoxicosis","author":"Lee","year":"1982","journal-title":"Ann Surg"},{"key":"key-10.4103\/0972-2327.248502-60","first-page":"908","volume-title":"Propranolol for the preoperative preparation of patients with thyrotoxicosis","author":"Caswell","year":"1978","journal-title":"Surg Gynecol Obstet"},{"key":"key-10.4103\/0972-2327.248502-61","first-page":"44","volume-title":"Phaeochromocytoma \u2013 Recent progress in its management","author":"Prys-Roberts","year":"2000","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0972-2327.248502-62","first-page":"508","volume-title":"Adrenergic blockade with phenoxybenzamine and propranolol in a cohort of 60 patients undergoing surgery for phaeochromocytoma","author":"Mihai","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"key-10.4103\/0972-2327.248502-63","first-page":"2649","volume-title":"Propranolol for severe hemangiomas of infancy","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0972-2327.248502-64","first-page":"735","volume-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0972-2327.248502-65","first-page":"182","volume-title":"Propranolol and infantile hemangiomas four years later: A systematic review","author":"Marqueling","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0972-2327.248502-66","doi-asserted-by":"crossref","unstructured":"L\u00e9aute-Labr\u00e8ze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebb\u00e9 G, et al. Safety of oral propranolol for the treatment of infantile hemangioma: A Systematic review. Pediatrics 2016;138. pii: e20160353.","DOI":"10.1542\/peds.2016-0353"},{"key":"key-10.4103\/0972-2327.248502-67","first-page":"245","volume-title":"Reactivating addiction-related memories under propranolol to reduce craving: A pilot randomized controlled trial","author":"Lonergan","year":"2016","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"key-10.4103\/0972-2327.248502-68","first-page":"1889","volume-title":"Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients","author":"Lindgren","year":"2013","journal-title":"Psychooncology"},{"key":"key-10.4103\/0972-2327.248502-69","first-page":"170","volume-title":"Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study","author":"Jang","year":"2017","journal-title":"Obstet Gynecol Sci"},{"key":"key-10.4103\/0972-2327.248502-70","first-page":"259","volume-title":"Propranolol safety profile in children","author":"El-Shabrawi","year":"2011","journal-title":"Curr Drug Saf"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:45Z","timestamp":1786714665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.AIAN_201_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["248502"],"URL":"https:\/\/doi.org\/10.4103\/aian.aian_201_18","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}